Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
39,573,391
-
Share change
-
-7,635,811
-
Total reported value
-
$86,388,477
-
Put/Call ratio
-
272%
-
Price per share
-
$2.18
-
Number of holders
-
61
-
Value change
-
-$14,086,783
-
Number of buys
-
32
-
Number of sells
-
27
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q3 2021
As of 30 Sep 2021 Aptose Biosciences Inc. - Common Shares had 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 39,573,391 shares of stock of the company.
Largest 10 holders included DRW Securities, LLC, Nantahala Capital Management, LLC, First Light Asset Management, LLC, 683 Capital Management, LLC, Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, MORGAN STANLEY, SANDERS MORRIS HARRIS LLC, GOLDMAN SACHS GROUP INC, and P.A.W. CAPITAL CORP.
This table shows 62 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.